Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase
Authors:
- Andrew J. WiemerAWAndrew J. Wiemer
- Huaxiang TongHTHuaxiang Tong
- Kelly M. SwansonKSKelly M. Swanson
- Raymond J. HohlRHRaymond J. Hohl
- 1 February 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 353 (4) , 921-925
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Ibandronate: A Clinical Pharmacological and Pharmacokinetic UpdateThe Journal of Clinical Pharmacology, 2004
- Rho and Rac Take Center StageCell, 2004
- Rab proteins as membrane organizersNature Reviews Molecular Cell Biology, 2001
- Small GTP-Binding ProteinsPhysiological Reviews, 2001
- Cellular and molecular mechanisms of action of bisphosphonatesCancer, 2000
- Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate SynthaseArchives of Biochemistry and Biophysics, 2000
- Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing BisphosphonatesBiochemical and Biophysical Research Communications, 1999
- Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.Journal of Clinical Oncology, 1998
- Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including RasJournal of Bone and Mineral Research, 1998
- Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activityBritish Journal of Haematology, 1997